01Principles and purposeThe professional or clinical skill and the decisions it supports.
Urinary infection in pregnancy can affect maternal health and has additional obstetric implications, so detected asymptomatic bacteriuria is treated rather than managed using the usual nonpregnant no-treatment rule. Symptomatic lower infection, pyelonephritis and maternal sepsis remain separate syndromes with different treatment intensity. Gestation, renal function, allergy and culture results determine a safe prescription; a drug suitable for bladder infection is not automatically suitable for renal infection.
Immunosuppression changes both risk and presentation, but does not create a single universal antibiotic algorithm. A renal transplant recipient with incidental bacteriuria differs from a febrile patient after myelosuppressive cancer treatment. In neutropenic sepsis, the immediate priority is emergency empirical treatment and oncology-led risk assessment. In transplantation, the assessment also considers graft function, recent instrumentation, resistant organisms and interactions with immunosuppressants. Do not apply the pregnancy bacteriuria rule indiscriminately across these groups.
Key points
- Treat detected significant asymptomatic bacteriuria in pregnancy using culture and a pregnancy-appropriate regimen; this treatment rule does not itself define an antenatal screening schedule. If upper infection instead requires intravenous cefuroxime, exclude cefuroxime or other cephalosporin hypersensitivity and severe hypersensitivity to another beta lactam.
- An unwell person receiving anticancer treatment may have neutropenic sepsis without a striking fever; arrange emergency assessment and immediate empirical treatment without waiting for the neutrophil result.
- For pregnant or recently pregnant patients aged sixteen or over who need sepsis fluid resuscitation, NG255 uses 500 ml crystalloid containing sodium 130–154 mmol/litre in under fifteen minutes, followed by reassessment.
- Pregnancy pyelonephritis needs a lower threshold for hospital advice and obstetric involvement; vomiting or severe illness requires an appropriate intravenous regimen.
- Routine antibiotic treatment of asymptomatic bacteriuria is not recommended simply because an adult has a renal transplant; recent procedures and individual specialist circumstances need separate assessment.
- Immunosuppression is not one uniform category: cancer-related neutropenia, transplantation, steroid exposure and other impaired defences differ in organism risk, interactions and clinical response.
02Situations and prioritiesThe context, relevant information and actions that matter most.
Establish gestational age, recent pregnancy status, urinary symptoms, fever, flank pain and oral intake. A culture-positive asymptomatic patient needs a different intensity of care from one with pyelonephritis, but both require an appropriate treatment decision.
New altered mental state, marked tachypnoea, hypotension, tachycardia or reduced urine output can indicate high-risk illness. Use NG255’s maternal risk criteria and urgent obstetric and senior assessment rather than substituting an adult NEWS2 threshold.
Ask when anticancer treatment was given and whether the patient feels acutely unwell. Neutropenic sepsis can occur with a neutrophil count at or below 0.5 × 10⁹/litre and fever above 38°C or other clinically significant sepsis features; do not wait for confirmation before initial emergency treatment.
In a transplant recipient, fever, graft-region discomfort, new urinary symptoms or graft dysfunction deserves prompt specialist assessment. A stable asymptomatic positive culture alone does not establish a treatment indication; recent surgery and planned urinary procedures require contextual review.
03Assessment and interpretationHow to gather information, assess the situation and recognise uncertainty.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Pregnancy urine culture and susceptibility - Why
- Identify an organism and select a suitable maternal treatment.
- Interpretation and limitations
- Obtain a midstream sample before antibiotics for symptomatic infection, and use significant detected bacteriuria to guide treatment even without symptoms. Mixed growth should prompt assessment of specimen quality; this recommendation does not prescribe when all pregnant people must be screened.
- 02
Immediate neutropenic sepsis investigations - Why
- Assess organ function and obtain cultures during emergency treatment.
- Interpretation and limitations
- Send full blood count, renal and liver tests, albumin, CRP, lactate and blood cultures, with urine culture when a urinary source is possible. Do not delay empirical antibiotics for the neutrophil count or perform routine chest radiography without a clinical indication.
- 03
Pregnancy appropriate upper tract imaging - Why
- Identify suspected obstruction or a complicated renal source.
- Interpretation and limitations
- Use ultrasound initially when an upper tract structural concern requires imaging, with specialist MRI or other imaging decisions where appropriate. Maternal deterioration or infected obstruction needs urgent source management, not an indefinite postponement because the patient is pregnant.
- 04
Transplant and immunosuppression review - Why
- Identify graft injury resistance or an important drug interaction.
- Interpretation and limitations
- Compare renal function with baseline, review cultures and recent devices, and ask the transplant or relevant specialist team about medicine interactions and appropriate imaging. Treat clinical infection while distinguishing it from isolated bacteriuria or a noninfectious cause of graft dysfunction.
04Worked approachesCases with ordered reasoning, an action and a check of the outcome.
01Worked caseTreat detected bacteriuria in pregnancyA twenty four week pregnant woman has significant bacteriuria found during an individually indicated urine assessment.+
- 1She has no dysuria, flank pain or fever and normal observations. Culture shows pure significant Escherichia coli growth, resistant to nitrofurantoin but susceptible to cefalexin. She has no beta lactam allergy, known renal disease or other evidence of an upper tract infection.
- 2She receives cefalexin 500 mg orally twice daily for seven days, with the positive culture and pregnancy treatment indication explained. She is told to seek prompt assessment for fever, loin pain, vomiting or feeling systemically unwell rather than assuming the existing bladder regimen covers every later syndrome.
- 3The obstetric team checks that she has completed treatment without a reaction. Because of her previous pyelonephritis history, it arranges an individual follow-up culture, which shows no growth; she remains clinically well.
- 4The result closes this episode and is shared with her maternity team. The case-specific follow-up specimen is not presented as a universal national test-of-cure or screening schedule, and further testing follows her ongoing clinical and maternity assessment.
02Worked caseTreat suspected neutropenic sepsis immediatelyA fifty eight year old man feels acutely unwell ten days after chemotherapy for lymphoma.+
- 1He has rigors, dysuria and temperature 38.3°C, with blood pressure 102/64 and no beta lactam allergy. Blood and urine cultures and urgent blood tests are obtained while the oncology emergency team starts treatment; the neutrophil result is not awaited.
- 2With creatinine clearance 84 ml/min and no relevant resistance or contraindication, he receives piperacillin/tazobactam 4 g/0.5 g intravenously every six hours, infused over thirty minutes. No aminoglycoside is routinely added, and a central venous catheter is not removed solely because it is present. A central line by itself also does not justify adding an empirical glycopeptide; a patient-specific or local microbiological indication is needed.
- 3The neutrophil count returns at 0.2 × 10⁹/litre. Urine and blood cultures later grow susceptible Escherichia coli, and targeted imaging finds no obstruction or collection. Oncology performs specialist risk assessment and reviews his clinical response and antibiotic choice daily.
- 4By forty eight hours he is haemodynamically stable and urinary symptoms have resolved. After seven days of directed treatment he remains afebrile with no uncontrolled focus; oncology judges the infection to have responded and stops antibiotics, although neutrophils remain 0.4 × 10⁹/litre. Before discharge, an oncology clinician reassesses him as low risk using a validated septic-complication score, confirms reliable home support, oral intake and transport, and gives clear instructions to return promptly for fever, rigors or feeling unwell. Next-day oncology review is arranged and confirms continued recovery. Seven days is this case’s reviewed endpoint, not a universal neutropenic-sepsis duration.
03Maternal deteriorationEscalate upper infection and sepsisA pregnant patient develops fever with flank pain, vomiting or concerning physiological change.+
- 1Arrange hospital and obstetric assessment, obtain appropriate urine and blood samples and give a pregnancy-suitable systemic antibiotic. In high-risk maternal sepsis, administer broad antimicrobial treatment within one hour of identifying a high-risk criterion.
- 2If intravenous fluid resuscitation is indicated in someone aged sixteen or over, give 500 ml crystalloid containing sodium 130–154 mmol/litre in less than fifteen minutes and reassess. A second bolus may be needed; lack of improvement after the second requires in-person consultant assessment, with earlier critical care involvement for severe illness.
- 3Look promptly for an obstructed kidney, collection or obstetric source and involve the teams able to control it. Maternal high-risk illness that fails to respond within one hour of an intervention requires consultant attendance; repeat assessment must not be replaced by waiting for culture results.
04Transplant assessmentInterpret an incidental positive cultureA stable renal transplant recipient has bacterial growth without new symptoms or graft dysfunction.+
- 1Confirm that the patient is genuinely asymptomatic and review the reason for testing, timing from surgery and any planned mucosa-breaching procedure. Seek transplant advice when early postoperative details or recent instrumentation make the situation less straightforward.
- 2Do not routinely prescribe an antibiotic merely because a renal transplant and bacteriuria coexist. EAU evidence does not support blanket treatment of asymptomatic bacteriuria in renal transplant recipients; a separate procedural indication is assessed on its own merits.
- 3Provide prompt review for fever, graft symptoms or deteriorating function, and do not independently stop immunosuppressants. Symptomatic infection requires source, susceptibility, renal dosing and interaction assessment with the specialist team.
05Relevant medicines and safetySpecific regimens and precautions when the skill involves prescribing.
Cefalexin 500 mg oral capsules in pregnancy
For the susceptible pregnancy lower UTI or detected asymptomatic bacteriuria example, prescribe 500 mg orally twice daily for seven days.Before this pregnancy course, exclude cefalexin, excipient or cephalosporin-group hypersensitivity and check renal function. A severe penicillin reaction calls for specialist antibiotic selection. Assess rash, severe diarrhoea and unexpected neurological symptoms. This seven day lower-tract course should not be silently transferred to pyelonephritis, which uses a different clinical assessment and a seven to ten day cefalexin framework when oral treatment is appropriate. Significant pure growth from an appropriate specimen already supports the pregnancy treatment decision; repeat sampling is for uncertainty such as mixed growth, not a prerequisite to treating this confirmed finding.
Piperacillin/tazobactam 4 g/0.5 g infusion
For the adult cancer-related neutropenic-sepsis example with clearance above 40 ml/min, give 4 g/0.5 g intravenously every six hours over thirty minutes, beginning immediately and reviewing daily.Check penicillin and other severe beta lactam allergy, renal function, potassium and blood counts. The selected product limits dosing to every eight hours at clearance 20–40 and every twelve hours below 20; dialysis needs its own advice. Review methotrexate and nephrotoxic combinations, especially vancomycin, and monitor serious rash, cytopenia, diarrhoea or seizures. Continuing and stopping treatment depends on specialist risk and clinical response, not neutrophil count alone. Discharge also requires validated low-risk specialist reassessment, a feasible home plan, return advice and follow-up.
Cefuroxime 1.5 g intravenous powder in pregnancy
For pregnancy pyelonephritis requiring intravenous treatment, an adult normal-renal-function option is 1.5 g every eight hours, infused over thirty to sixty minutes; review intravenous need within forty eight hours.Cefuroxime, excipient or other cephalosporin hypersensitivity is a contraindication; so is a history of severe hypersensitivity to another beta lactam. At creatinine clearance 10–20 the selected product uses 750 mg every twelve hours, and below 10 it uses 750 mg daily; do not retain a normal renal schedule during significant deterioration. Consider nephrotoxic medicines, anticoagulants, antibiotic-associated diarrhoea and neurological toxicity from accumulation.
06Feedback, follow-up and evidenceReview outcomes, seek feedback and identify what to improve.
- Give the pregnant patient clear advice about new fever, flank pain, vomiting and systemic symptoms, and ensure that a named team reviews culture results and any change in treatment.
- In maternal sepsis, monitor high-risk patients continuously or at least every thirty minutes as appropriate, reassessing mental state and response to each intervention with prompt consultant escalation when needed.
- For suspected or confirmed neutropenic sepsis, use specialist validated risk assessment and daily review. Persistent fever alone in a stable patient does not automatically justify a different empirical drug or routine aminoglycoside addition. Before discharge, document specialist reassessment as low risk using a validated score, feasible social and clinical circumstances, prompt-return instructions and a named review plan.
- In transplant recipients, follow symptoms and graft function and check clinically relevant antimicrobial interactions. Changes to immunosuppression require the specialist team rather than a generic instruction to stop all immune-modifying treatment.
07Special situationsVariants, exceptions and circumstances that change the usual approach.
Three populations three decisions
Pregnancy changes the treatment of detected asymptomatic bacteriuria, transplantation does not create the same blanket rule, and cancer-related neutropenia changes emergency empirical treatment. Keeping those decisions separate prevents both undertreatment and unnecessary antibiotics.
Gestation changes medicine safety
Nitrofurantoin is unsuitable at term and cannot treat pyelonephritis; trimethoprim is contraindicated in the first trimester for the selected product. Culture, gestation and the affected site should guide alternatives rather than a blanket statement that any UTI drug is safe in pregnancy.
Neutropenic signs can be muted
An acutely unwell person after anticancer treatment needs urgent assessment even without a dramatic temperature or local inflammatory response. A normal-looking urine dipstick cannot be used to postpone the systemic emergency pathway.
Avoid transplant prescribing shortcuts
Reduced kidney function, calcineurin inhibitors and other concomitant drugs can change antimicrobial safety. Fluoroquinolone tendon risk is greater with transplantation and corticosteroids, reinforcing the need for an individual alternative and interaction assessment.
Candiduria requires its own assessment
Fungal growth may be colonisation, but neutropenia, symptoms, obstruction or a planned mucosa-breaching procedure changes the question. Obtain specialist advice on species, susceptibility and source control rather than treating every immunosuppressed positive sample alike.
08Common pitfallsFrequent interpretation and management errors.
- 01
Leaving significant pregnancy bacteriuria untreated because there are no symptoms incorrectly applies the usual nonpregnant asymptomatic rule.
- 02
Giving antibiotics to every asymptomatic renal transplant recipient imports a pregnancy exception into a population where routine treatment is not supported.
- 03
Waiting for the neutrophil result or a high NEWS2 before treating an unwell patient after anticancer therapy can delay emergency neutropenic-sepsis care.
- 04
Copying the NG253 250 ml adult bolus into the maternal pathway, or copying the maternal 500 ml bolus into all adults, mixes distinct current recommendations.
- 05
Changing empirical neutropenic-sepsis treatment solely for persistent fever without deterioration or microbiological evidence can add toxicity without resolving a source or diagnostic problem.